Education
About Us
Working with TipRanks
Follow Us
Applied Therapeutics Inc (APLT)
NASDAQ:APLT
govorestat
Charcot-Marie-Tooth Disease With Sorbitol Dehydrogenase Deficiency (Cmt-Sord)
Phase III
Not Yet Recruiting
Confirmatory Study of Govorestat in CMT-SORD
Sep 10, 2025
―
At-007
Hereditary Neuropathy Caused By Sord Deficiency
Phase II/III
Active Not Recruiting
Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients With Sorbitol Dehydrogenase (SORD) Deficiency
May 23, 2022
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Applied Therapeutics Inc (APLT) have in its pipeline
APLT is currently developing the following drugs: govorestat, At-007. These drug candidates are in various stages of clinical development as the company works toward FDA approval.